Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Accounts Payables (2022 - 2025)

Historic Accounts Payables for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to $1.3 million.

  • CervoMed's Accounts Payables rose 2464.67% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 2464.67%. This contributed to the annual value of $1.5 million for FY2024, which is 12815.19% up from last year.
  • CervoMed's Accounts Payables amounted to $1.3 million in Q3 2025, which was up 2464.67% from $1.8 million recorded in Q2 2025.
  • CervoMed's Accounts Payables' 5-year high stood at $1.9 million during Q1 2025, with a 5-year trough of $97302.0 in Q4 2022.
  • Its 4-year average for Accounts Payables is $981262.7, with a median of $846032.0 in 2022.
  • Within the past 5 years, the most significant YoY rise in CervoMed's Accounts Payables was 58084.01% (2023), while the steepest drop was 3388.55% (2023).
  • Quarter analysis of 4 years shows CervoMed's Accounts Payables stood at $97302.0 in 2022, then skyrocketed by 580.84% to $662471.0 in 2023, then skyrocketed by 128.15% to $1.5 million in 2024, then dropped by 10.73% to $1.3 million in 2025.
  • Its Accounts Payables was $1.3 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.9 million in Q1 2025.